Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Unilabs lands unexpected buyer

Global lab company Unilabs has been acquired by A.P. Moller Holding, an investment company owned by the Maersk family, who own global supply chain and logistics businesses. 

PAI Partners and Ontario Teachers’ buy Veonet

HBI has been told that Paris based private equity firm PAI Partners and Ontario Teachers' Pension Plan Board have agreed to acquire Germany based ophthalmology network Veonet from Nordic Capital.

Vivalto Santé to hoover up hospitals after LBO

Vivalto Partners, a new investment fund founded by the CEO of France's third-largest hospital group Vivalto Santé, has bought a controlling stake in the hospital group. HBI hears that Vivalto Santé will focus on further consolidating western France while Vivalto Partners wants to acquire other healthcare businesses.

Labs could be next on property block

Life science properties that incorporate some laboratories in one form or another could be the next property boom says Piers Scrimshaw-Wright, who has just joined Knight Frank as Life Science and Innovation partner. So has anything been sold in Europe so far?

Residential propco deals blow up post-COVID

This week HBI looks at the volumes of property deals at Europe's three biggest healthcare REITs by the number of sites purchased. More residential care providers are selling off properties than the year before the pandemic hit. 

$7bn Indian insurance IPO fails to cover book

Indian private health insurer Star Health has seen just short of four-fifths of its IPO offer subscribed in the past three days of book building. However, local press reports that the listing will still go through thanks to a downsized secondary offer.

Russian oxygen supplies dwindle

Parts of Russia are facing significant oxygen shortages as the treatment of Covid patients continues to chip away at reserves.

IHH considers divesting in China

Listed Malaysian hospital group IHH Healthcare is considering a divestment of its loss-making Chinese business, it has told the stock exchange. Parkway Group could sell for US$1bn.

Booster blunder puts staff at risk

The Indian government's slowness to approve booster shots is putting lives at risk - particularly those of front line medical staff whose immunity is waning. HBI speaks to a disappointed operator source in the country to find out more.

Find Us